CTLA4 is associated with susceptibility to multiple sclerosis

Journal of Neuroimmunology

Volumn 134, Issue 1-2, 2003, Pages 133-141

  Kantarci, Orhun H ^a   Hebrink, David D ^a   Achenbach, Sara J ^a   Atkinson, Elizabeth J ^a   Waliszewska, Alicja ^b   Buckle, Guy ^b   McMurray, Cynthia T ^a   De Andrade, Mariza ^a   Hafler, David A ^b   Weinshenker, Brian G ^a  

^a MAYO CLINIC   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CTLA 4; Multiple sclerosis; Polymorphism; Prognosis; Severity; Susceptibility

Indexed keywords

AGE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ETHNOLOGY; FAMILY; GENDER; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PARAMETERS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; ONSET AGE; PEDIGREE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK;

AGE OF ONSET; ALTERNATIVE SPLICING; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BOSTON; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HAPLOTYPES; HUMANS; IMMUNOCONJUGATES; LINKAGE (GENETICS); MALE; MICROSATELLITE REPEATS; MINNESOTA; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 0037223518     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00395-8     Document Type: Article

References (40)

1. Allegre M.L., Shiels H., Thompson C.B., Gajeuski T.F. Expression and function of CTLA-4 in Th1 and Th2 cells. Journal of Immunology. 161:1998;3347-3356.
2. Anderson D.E., Katarzyna B.D., Bar-Or A., Oliveira E.M.L., Carreno B., Collins M., Hafler D.A. Paradoxical inhibition of T cell function in response to CTLA-4 blockade; heterogeneity within the human T cell population. Nature Medicine. 2:2000;211-214.
3. Braun J., Donner H., Siegmund T., Walfish P.G., Usadel K.H., Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens. 51(5):1998;563-566.
4. Bruzzi P., Green S.B., Byar D.P., Brinton L.A., Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. American Journal of Epidemiology. 122:1985;904-914.
5. Chambers C.A., Sullivan T.J., Allison J.P. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity. 7(6):1997;885-895.
6. Chataway J., Feakes R., Coraddu F., Gray J., Deans J., Fraser M., Robertson N., Broadley S., Jones H., Clayton D., Goodfellow P., Sawcer S., Compston A. The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain. 121(Pt 10):1998;1869-1887.
7. Clayton D. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. American Journal of Human Genetics. 65:1999;1170-1177.
8. Cross A.H., Girard T.J., Giacoletto K.S., Evans R.J., Keeling R.M., Lin R.F., Trotter J.L., Karr R.W. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. Journal of Clinical Investigation. 95(6):1995;2783-2789.
9. Doyle A.M., Mullen A.C., Villarino A.V., Hutchins A.S., High F.A., Lee H.W., Thompson C.B., Reiner S.L. Induction of cytotoxic T lymphocyte antigen 4 (CTLA-4) restricts clonal expansion of helper T cells. Journal of Experimental Medicine. 194(7):2001;893-902.
10. Dyment D.A., Steckley J.L., Willer C.J., Armstrong H., Sadovnick A.D., Risch N., Ebers G.C. No evidence to support CTLA-4 as a susceptibility gene in Canadian MS families. Journal of Neuroimmunology. 123:2002;193-198.
11. Ebers G.C., Kukay K., Bulman D.E., Sadovnick A.D., Rice G., Anderson C., Armstrong H., Cousin K., Bell R.B., Hader W., Paty D.W., Hashimoto S., Oger J., Duquette P., Warren S., Gray T., O'Connor P., Nath A., Auty A., Metz L., Francis G., Paulseth J.E., Murray T.J., Pryse-Phillips W., Risch N. A full genome search in multiple sclerosis. Nature Genetics. 13(4):1996;472-476.
12. Fukazawa T., Yanagawa T., Kikuchi S., Yabe I., Sasaki H., Hamada T., Miyasaka K., Gomi K., Tashiro K. CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients. Journal of the Neurological Sciences. 171(1):1999;49-55.
13. Gimmi C.D., Freeman G.J., Gribben J.G., Gray G., Nadler L.M. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proceedings of the National Academy of Sciences of the United States of America. 90(14):1993;6586-6590.
14. Goodkin D.E., Doolittle T.H., Hauser S.S., Ransohoff R.M., Roses A.D., Rudick R.A. Diagnostic criteria for multiple sclerosis research involving multiple affected families. Archives of Neurology. 48:1991;805-807.
15. Haines J., Pericak-Vance M., Seboun E., Hauser S. A complete genomic screen for multiple sclerosis underscores a role for the major hitocompatibility complex. Nature Genetics. 13:1996;469-471.
16. Harbo H.F., Celius E.G., Vartdal F., Spurkland A. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens. 53(1):1999;106-110.
17. Huang D., Liu L., Noren K., Xia S.Q., Trifunovic J., Pirskanen R., Lefvert A.K. Genetic association of CTLA-4 to myasthenia gravis with thymoma. Journal of Neuroimmunology. 88(1-2):1998;192-198.
18. Kantarci O.H., Atkinson E.J., Hebrink D.D., McMurray C.T., Weinshenker B.G. Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis. Journal of Neuroimmunology. 106(1-2):2000;220-227.
19. Khoury S.J., Akalin E., Chandraker A., Turka L.A., Linsley P.S., Sayegh M.H., Hancock W.W. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. Journal of Immunology. 155(10):1995;4521-4524.
20. Krummel M.F., Allison J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. Journal of Experimental Medicine. 183(6):1996;2533-2540.
21. Kuokkanen S., Gschwend M., Rioux J.D., Daly M.J., Terwilliger J.D., Tienari P.J., Wikstrom J., Palo J., Stein L.D., Hudson T.J., Lander E.S., Peltonen L. Genomewide scan of multiple sclerosis in Finnish multiplex families. American Journal of Human Genetics. 61(6):1997;1379-1387.
22. Lathrop G.M., Ott J. Analysis of complex diseases under oligogenic models and intrafamilial heterogeneity by the LINKAGE programs. American Journal of Human Genetics. 47:1990;A188.
23. Ligers A., Xu C., Saarinen S., Hillert J., Olerup O. The CTLA-4 gene is associated with multiple sclerosis. Journal of Neuroimmunology. 97(1-2):1999;182-190.
24. Ligers A., Teleshova N., Masterman T., Huang W.X., Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes and Immunity. 2(3):2001;145-152.
25. Liu Q., Sommer S. Parameters affecting the sensitivities of dideoxyfingerprinting and SSCP. PCR Methods and Applications. 4:1994;97-108.
26. Nistico L., Buzzetti R., Pritchard L.E., Van der Auwera B., Giovannini C., Bosi E., Larrad M.T., Rios M.S., Chow C.C., Cockram C.S., Jacobs K., Mijovic C., Bain S.C., Barnett A.H., Vandewalle C.L., Schuit F., Gorus F.K., Tosi R., Pozzilli P., Todd J.A. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Human Molecular Genetics. 5(7):1996;1075-1080.
27. Perez V.L., Van Parijs L., Biuckians A., Zheng X.X., Strom T.B., Abbas A.K. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity. 6(4):1997;411-417.
28. Rasmussen H.B., Kelly M.A., Francis D.A., Clausen J. CTLA4 in multiple sclerosis. Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese. Journal of the Neurological Sciences. 184(2):2001;143-147.
29. Risch N., Merikangas K.R. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
30. Rodriguez M., Siva A., Ward J., Stolp-Smith K., O'Brien P., Kurland L. Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota. Neurology. 44:1994;78-83.
31. Sawcer S., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P.N., Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genetics. 13(4):1996;464-468.
32. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. American Journal of Human Genetics. 70:2002;425-434.
33. Seidl C., Donner H., Fischer B., Usadel K.H., Seifried E., Kaltwasser J.P., Badenhoop K. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens. 51(1):1998;62-66.
34. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium. The insulin gene region and insulin-dependent diabetes mellitus (IDDM). American Journal of Human Genetics. 52:1993;506-516.
35. Thompson C.B., Allison J.P. The emerging role of CTLA-4 as an immune attenuator. Immunity. 7(4):1997;445-450.
36. Weinshenker B.G., Wingerchuk D.M., Liu Q., Bissonet A.S., Schaid D.J., Sommer S.S. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis. Neurology. 49(2):1997;378-385.
37. Weinshenker B.G., Santrach P., Bissonet A.S., McDonnell S.K., Schaid D., Moore S.B., Rodriguez M. Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology. 51(3):1998;742-747.
38. Weinshenker B.G., Hebrink D., Kantarci O.H., Schaefer-Klein J., Atkinson E., Schaid D., McMurray C.M. Genetic variation in the transforming growth factor beta1 gene in multiple sclerosis. Journal of Neuroimmunology. 120(1-2):2001;138-145.
39. Weir W.S. Genetic Data Analysis. vol. II:1996;91-140 Sinauer, Massachusetts.
40. Yanagawa T., Hidaka Y., Guimaraes V., Soliman M., DeGroot L.J. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. Journal of Clinical Endocrinology and Metabolism. 80(1):1995;41-45.